Aller au contenu principal
Fermer

Sanofi in agreement with Janssen to develop E. coli the vaccine candidate
information fournie par Reuters 03/10/2023 à 07:44

Le logo de Sanofi à Lyon

Le logo de Sanofi à Lyon

PARIS (Reuters) - Sanofi on Tuesday announced it had reached an agreement with Janssen, a part of Johnson & Johnson, to develop and commercialize a vaccine candidate for extra-intestinal pathogenic E.coli.

Under the terms of the deal, both parties will co-fund current and future research and development costs. Sanofi will pay $175 million upfront to Janssen, followed by development and commercial milestones.

(Reporting by Tassilo Hummel; Editing by Benoit Van Overstraeten)

Valeurs associées

224,200 USD NYSE -1,32%
77,810 EUR Euronext Paris -2,52%

1 commentaire

  • 03 octobre 09:06

    On est en FRANCE, Ecrivez en Français !!


Signaler le commentaire

Fermer

A lire aussi

Mes listes

Cette liste ne contient aucune valeur.
Chargement...